Literature DB >> 24102818

Benign papillomas diagnosed on large-gauge vacuum-assisted core needle biopsy which span <1.5 cm do not need surgical excision.

Andrew D Mosier1, Joren Keylock, Donald V Smith.   

Abstract

The objective of our study is to determine if a carefully selected subset of benign breast papillomas (size ≤1.5 cm) can be safely followed by imaging surveillance instead of immediate surgical excision. Over a 6½-year period, 86 breast lesions were diagnosed as a benign papilloma (BP) utilizing an 11- or 8-gauge vacuum-assisted core needle biopsy (VACNB) device. In general, it was our intent to remove as much of the radiologically evident lesion as possible. These 86 lesions underwent ≥2 years of imaging surveillance, without surgical excision following initial detection. With ≥2 years of radiologic follow-up, none of the 86 BPs demonstrated imaging findings that necessitated repeat biopsy or surgical excision. Benign breast papillomas ≤1.5 cm that are biopsied using an 11- or 8-gauge VACNB device with intent to remove as much of the radiologically evident lesion as possible are safe to undergo serial imaging surveillance rather than immediate surgical excision.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  benign papilloma; intraductal papilloma; papilloma excision

Mesh:

Year:  2013        PMID: 24102818     DOI: 10.1111/tbj.12180

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  8 in total

Review 1.  How Do We Approach Benign Proliferative Lesions?

Authors:  Faina Nakhlis
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

2.  Prediction of postoperative hematoma occurrence after ultrasound-guided vacuum-assisted breast biopsy in minimally invasive surgery for percutaneous removal of benign breast lesions.

Authors:  Jianwei Zheng; Shuyan Cai; Huimin Song; Yunlei Wang; Xiaofeng Han; Gang Han; Haoliang Wu; Zhigang Gao
Journal:  Gland Surg       Date:  2020-10

Review 3.  Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?

Authors:  Marco Lucioni; Chiara Rossi; Pascal Lomoro; Francesco Ballati; Marianna Fanizza; Alberta Ferrari; Carlos A Garcia-Etienne; Emanuela Boveri; Giulia Meloni; Maria Grazia Sommaruga; Elisa Ferraris; Angioletta Lasagna; Elisabetta Bonzano; Marco Paulli; Adele Sgarella; Giuseppe Di Giulio
Journal:  Eur Radiol       Date:  2020-08-20       Impact factor: 5.315

Review 4.  High-risk lesions of the breast: concurrent diagnostic tools and management recommendations.

Authors:  Francesca Catanzariti; Daly Avendano; Giuseppe Cicero; Margarita Garza-Montemayor; Carmelo Sofia; Emmanuele Venanzi Rullo; Giorgio Ascenti; Katja Pinker-Domenig; Maria Adele Marino
Journal:  Insights Imaging       Date:  2021-05-26

5.  Predictive Factors for Upgrading Patients with Benign Breast Papillary Lesions Using a Core Needle Biopsy.

Authors:  Young Ran Hong; Byung Joo Song; Sang Seol Jung; Bong Joo Kang; Sung Hun Kim; Byung Joo Chae
Journal:  J Breast Cancer       Date:  2016-12-23       Impact factor: 3.588

Review 6.  Ultrasonographic evaluation of women with pathologic nipple discharge.

Authors:  Jung Hyun Yoon; Haesung Yoon; Eun-Kyung Kim; Hee Jung Moon; Youngjean Vivian Park; Min Jung Kim
Journal:  Ultrasonography       Date:  2017-04-09

7.  Papillomas of the breast: factors associated with underestimation.

Authors:  Gabriela Boufelli; Marcelo A Giannotti; Carlos A Ruiz; Nestor de Barros; Luciano F Chala; Jonathan Y Maesaka; Rodrigo Goncalves; Bárbara H Bresciani; Paula Vianna; José M Soares; Edmund C Baracat; José R Filassi
Journal:  Eur J Cancer Prev       Date:  2018-07       Impact factor: 2.497

8.  First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).

Authors:  Christoph J Rageth; Elizabeth Am O'Flynn; Christopher Comstock; Claudia Kurtz; Rahel Kubik; Helmut Madjar; Domenico Lepori; Gert Kampmann; Alexander Mundinger; Astrid Baege; Thomas Decker; Stefanie Hosch; Christoph Tausch; Jean-François Delaloye; Elisabeth Morris; Zsuzsanna Varga
Journal:  Breast Cancer Res Treat       Date:  2016-08-13       Impact factor: 4.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.